Measured Wealth Private Client Group, LLC

SEC CIK: 0001720235
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Measured Wealth Private Client Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2026): 394
Value: $30.8K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of HALO by Measured Wealth Private Client Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	394	$30.8K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	394	$25.5K	<0.1%	+29+7.9%	Added	Holders
Q4 2025	365	$24.6K	<0.1%	+124+51.5%	Added	Holders
Q3 2025	241	$17.7K	<0.1%	+241	New	Holders